CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 464 enrolled
Drug / intervention
bimatoprost formulation A solution +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01698554
NCT01698554Phase 3Completed
CompareCT.gov

Bimatoprost in the Treatment of Eyelash Hypotrichosis

Allergan·interventional·Posted Oct 3, 2012·Updated Feb 10, 2015

In Brief

A Phase 3 clinical trial evaluating bimatoprost formulation A solution, bimatoprost solution 0.03 %, and 2 other interventions for Idiopathic Eyelash Hypotrichosis. Completed, enrolled 464 participants across 4 sites in 4 countries.

Detailed Summary

This study will evaluate the safety and efficacy of bimatoprost solution formulation A compared with bimatoprost solution 0.03% (LATISSE®) and vehicle in the treatment of eyelash hypotrichosis (inadequate eyelashes).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIdiopathic Eyelash Hypotrichosis
CountriesRussia, Sweden, United Kingdom, United States
Collaborators--

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedOct 3, 2012
Enrollment StartNov 1, 2012
Primary CompletionFeb 1, 2014
Study CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 13.7 years ago

Interventions

bimatoprost formulation A solutiondrug

Bimatoprost formulation A solution applied to the upper eyelid of both eyes once daily for 4 months using the supplied applicator.

bimatoprost solution 0.03 %drug

Bimatoprost solution 0.03 % (LATISSE®) applied to the upper eyelid of both eyes once daily for 4 months using the supplied applicator.

vehicle of bimatoprost formulation A solutiondrug

Vehicle of bimatoprost formulation A solution applied to the upper eyelid of both eyes once daily for 4 months using the supplied applicator.

vehicle of bimatoprost solution 0.03 %drug

Vehicle of bimatoprost solution 0.03 % applied to the upper eyelid of both eyes once daily for 4 months using the supplied applicator.